Drug
Td
Td is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_2
5
100%
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
5(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 25 (100.0%)
Trials by Status
completed480%
active_not_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruitingphase_2
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
NCT03688178
completedphase_2
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
NCT02465268
completedphase_2
DC Migration Study for Newly-Diagnosed GBM
NCT02366728
completedphase_2
Pertussis Maternal Immunization Study
NCT00553228
completedphase_2
Maternal Tdap Immunization in Guatemala
NCT02301702
Clinical Trials (5)
Showing 5 of 5 trials
NCT03688178Phase 2
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
NCT02465268Phase 2
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme
NCT02366728Phase 2
DC Migration Study for Newly-Diagnosed GBM
NCT00553228Phase 2
Pertussis Maternal Immunization Study
NCT02301702Phase 2
Maternal Tdap Immunization in Guatemala
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5